The objective of this whitepaper is to introduce the concept of One-Vigilance® within the context of the current drug safety landscape. It emphasizes the importance of directing the focus of pharmacovigilance experts towards a strategic orientation, while also considering the novel contributions of technology, digital innovation, patient focus, and real-world data.

Additionally, the whitepaper aims to provide key insights to catalyze the efficiencies of corporate Centers of Excellence in pharmacovigilance. By highlighting these aspects, the whitepaper seeks to encourage a more holistic and forward-thinking approach to drug safety management.